{{Rsnum
|rsid=7170178
|Chromosome=15
|position=60341655
|Orientation=plus
|GMAF=0.3857
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 43.5 | 40.7 | 15.7
| HCB | 41.5 | 43.0 | 15.6
| JPT | 25.9 | 51.8 | 22.3
| YRI | 27.1 | 50.7 | 22.2
| ASW | 26.8 | 57.1 | 16.1
| CHB | 41.5 | 43.0 | 15.6
| CHD | 32.1 | 48.6 | 19.3
| GIH | 45.5 | 46.5 | 7.9
| LWK | 22.7 | 49.1 | 28.2
| MEX | 58.6 | 37.9 | 3.4
| MKK | 26.5 | 51.0 | 22.6
| TSI | 39.2 | 50.0 | 10.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=22822523
|Title=Effect of ANXA2 gene single nucleotide polymorphism (SNP) on the development of osteonecrosis in indian sickle cell patient: a PCR-RFLP approach
}}

{{PMID|15784727|OA=1
}} Association of klotho, bone morphogenic protein 6, and annexin A2 polymorphisms with sickle cell osteonecrosis.

{{PMID|20401335|OA=1
}} Sickle Cell Disease in the Post Genomic Era: A Monogenic Disease with a Polygenic Phenotype.

{{on chip | Affy GenomeWide 6}}